Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paige Lewis

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Vaccine|February 14, 2015
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014Penina Haber, Pedro L Moro, Maria Cano, et al.
Plos Neglected Tropical Diseases|July 14, 2016
Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015Pedro L Moro, Emily Jane Woo, Wendy Paul, et al.
Pediatrics|June 6, 2018
Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) VaccinesPedro L Moro, Silvia Perez-Vilar, Paige Lewis, et al.
Vaccine|March 26, 2016
Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015Pedro L Moro, Janet Cragan, Naomi Tepper, et al.
Journal of the American Geriatrics Society|April 3, 2007
A multidisciplinary management program in primary care to improve hypertension control and healthy behaviors in elderly patientsIhab M Hajjar, Brandy Dickson, Jennifer L Blackledge, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012Penina Haber, Pedro L Moro, Maria Cano, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012Penina Haber, Pedro L Moro, Maria Cano, et al.
Vaccine|April 19, 2016
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013Elaine R Miller, Pedro L Moro, Maria Cano, et al.
Vaccine|December 16, 2014
Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013Pedro L Moro, Yenlik Zheteyeva, Paige Lewis, et al.
The Journal of Pediatrics|January 20, 2015
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013Pedro L Moro, Christopher Jankosky, David Menschik, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Vaccine|February 14, 2015
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014Penina Haber, Pedro L Moro, Maria Cano, et al.
Plos Neglected Tropical Diseases|July 14, 2016
Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015Pedro L Moro, Emily Jane Woo, Wendy Paul, et al.
Pediatrics|June 6, 2018
Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) VaccinesPedro L Moro, Silvia Perez-Vilar, Paige Lewis, et al.
Vaccine|March 26, 2016
Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015Pedro L Moro, Janet Cragan, Naomi Tepper, et al.
Journal of the American Geriatrics Society|April 3, 2007
A multidisciplinary management program in primary care to improve hypertension control and healthy behaviors in elderly patientsIhab M Hajjar, Brandy Dickson, Jennifer L Blackledge, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012Penina Haber, Pedro L Moro, Maria Cano, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012Penina Haber, Pedro L Moro, Maria Cano, et al.
Vaccine|April 19, 2016
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013Elaine R Miller, Pedro L Moro, Maria Cano, et al.
Vaccine|December 16, 2014
Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013Pedro L Moro, Yenlik Zheteyeva, Paige Lewis, et al.
The Journal of Pediatrics|January 20, 2015
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013Pedro L Moro, Christopher Jankosky, David Menschik, et al.
Pageof 6